Behavioural activation for depression; an update of meta-analysis of effectiveness and sub group analysis.
Ekers D, Webster L, Van Straten A, Cuijpers P, Richards D, Gilbody S. · 2014
Read Behavioural activation for depression; an update of meta-analysis of effectiveness and sub group analysis. by Ekers D, Webster L, Van Straten A, Cuijpers P, Richards D, Gilbody S. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4061095.txt.
Introduction
David Ekers and colleagues updated a meta-analysis of behavioural activation, a talk therapy for depression that helps people re-engage with rewarding daily activities. Their review appeared in PLoS ONE in 2014. Earlier summaries were more than five years old, and interest in the therapy had grown.
Pooling twenty-six randomised trials with more than fifteen hundred subjects, the authors found behavioural activation beat control conditions on depression symptoms after treatment. It also came out ahead of antidepressant medication in the few trials that compared them. Most studies were of low quality with short follow-up, and the authors saw no sign of publication bias. They call for stronger, longer trials to firm up the evidence.
Catalog record
| CREATOR | Ekers D, Webster L, Van Straten A, Cuijpers P, Richards D, Gilbody S. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Behavioural Activation for Depression; An Update of Meta-Analysis of Effectiveness and Sub Group Analysis By David Ekers, Lisa Webster, Annemieke Van Straten, Pim Cuijpers, David Richards, Simon Gilbody, André Aleman Published in: PLoS ONE DOI: 10.1371/journal.pone.0100100 ABSTRACT Background Depression is a common, disabling condition for which psychological treatments are recommended. Behavioural activation has attracted increased interest in recent years. It has been over 5 years since our meta-analyses summarised the evidence supporting and this systematic review updates those findings and examines moderators of treatment effect. Method Randomised trials of behavioural activation for depression versus controls or anti-depressant medication were identified using electronic database searches, previous reviews and reference lists. Data on symptom level and study level moderators were extracted and analysed using meta-analysis, sub-group analysis and meta-regression respectively. Results Twenty six randomised controlled trials including 1524 subjects were included in this meta-analysis. A random effects meta-analysis of symptom level post treatment showed behavioural activation to be superior to controls (SMD −0.74 CI −0.91 to −0.56, k = 25, N = 1088) and medication (SMD −0.42 CI −0.83 to-0.00, k = 4, N = 283). Study quality was low in the majority of studies and follow- up time periods short. There was no indication of publication bias and subgroup analysis showed limited association between moderators and effect size. Conclusions The results in this meta-analysis support and strengthen the evidence base indicating Behavioural Activation is an effective treatment for depression. Further high quality research with longer term follow-up is needed to strengthen the evidence base. INTRODUCTION Depression is the most common mental disorder in community settings [1] and recent predictions state that by 2030 it will be the leading cause of disease burden in high-income countries [2]. NICE [1] promote the use of cognitive behavioural therapy (CBT) combining both behavioural and cognitive techniques. More recently a meta-analysis has suggested equivalence across most psychotherapies for depression [3]. If this is the case the idea of parsimony, using the least complex but acceptable theoretically derived treatment, may offer considerable benefit in terms of stability and distribution of the chosen intervention. Behavioural Activation (BA) may be one such parsimonious treatment option. It uses the principles of operant conditioning through scheduling to encourage depressed people to reconnect with environmental positive reinforcement. Whereas more complex therapies such as CBT require 1–2 years of intensive training for therapists to acquire the wide range of competencies the relative small set of techniques necessary for effective delivery of BA may be possible to acquire after 5 days [4]. It has been 5 years since we conducted the searches for our previous two meta-analyses which indicated BA offered an effective and simple intervention in 16 and 17 randomised controlled trials respectively [5], [6]. This systematic review and meta-analysis updates our previous work exploring the effectiveness of BA as a psychological therapy for depression compared to usual care as we were aware that new studies had been conducted. In addition we explore the relationship of study level moderators such as therapist training level, delivery mode, multi-morbidity, number of sessions and severity with treatment effect. The review also adds to the current evidence base by extending the review to explore BA compared to anti-depressant medication. METHODS Identification and Selection of Studies We included studies identified in previous meta-analyses [5], [6] and cross referenced with on additional BA review [7]. In addition we searched a database of 352 psychotherapy studies of depression. This database has been used in a series of published meta-analysis examining depression (www.evidencebasedpsychotherapies.org) and has been described in detail elsewhere [8]. It is updated yearly using a systematic and comprehensive review of all published evidence (1966 to January 2013) and included 14,164 abstracts (3,638 from pubmed, 2,824 from psycinfo, 4,682 from embase, and 3,020 from the Cochrane Central Register of Controlled Trials). Reference lists of identified studies and meta-analyses were examined to ensure no studies had been missed. Finally key researchers in BA were contacted to identify any missed studies or studies in press. Inclusion Criteria We included all randomised controlled trials for adult (≥16 years) patients with a primary diagnosis of depression who were treated in community or in-patient settings with BA. BA was defined as a behaviourally oriented time limited psychotherapeutic intervention including key elements of self-monitoring and activity scheduling. As BA is a relatively recent term used to describe this intervention we also included studies of behavioural therapy for depression if self-monitoring and activity scheduling were core elements of the intervention. Comparators consisted of a range of waiting list, placebo and usual care. We did not explore the comparative effectiveness of BA with other psychotherapies as this has been updated in other recent reviews [3], [9] [9], [10]. We also explored studies where BA had been compared with antidepressant medication. This comparison has been missing in previous reviews and represents an important consideration as antidepressants remain the most commonly received treatment for depression [11]. We included studies in any language to reduce the risk of potential publication bias. Studies excluded were those which included participants with psychosis or bipolar disorder, substance misuse problems, cognitive impairment or without depression as a primary diagnosis. Study Level Moderators Subgroup analyses were conducted to explore any potential dispersion across results. We investigated the moderating effects of: - Group/Individual therapy - Clinical/non clinical populations (i.e. student samples) - Recruitment setting/approach - Baseline depression severity - Method of depression categorisation at assessment - Level of therapist experience (psychotherapist/psychologist compared to specifically trained non specialist) - Control type - Number of sessions - Quality of included studies. In addition we explored the type of behavioural treatment employed in the study and if these were associated with effect. We examined the number of the elements currently considered core to BA (self-monitoring, activity scheduling, functional analysis, values assessment) included in each study as a continuous variable and if the treatment were considered simple BA (predominantly self-monitoring and scheduling) or complex BA (self-monitoring, scheduling plus additional behavioural components such as functional analysis and/or values focussed interventions). This subgroup analysis represented an important consideration as more complex BA studies have been excluded from recent reviews [9] as they were deemed to represent ‘third wave CBT’. This classification is not commonly accepted however and careful consideration of the cumulative effect of intervention components would represent useful new data relevant to this debate. Outcome Measures Our primary outcome measure was depression symptom level, collected either via self-rated or via clinician-rated measures. Where studies included multiple symptom measures, all data were entered and the mean effect was calculated, so that each study provided one estimate of effect. Quality Assessment Quality of studies was rated according to the Cochrane Collaboration’s Tool for Assessing Risk of Bias [12]. The elements used were; - Adequate generation of randomisation sequence - Allocation concealment - Blinding of assessment - Dealing with missing data. Due to the difficulties of blinding participants, therapists and other associated health professionals in psychotherapy studies, this quality factor was excluded. Each study was scored against the above to provide a score of between 0 and 4. Data Extraction and Sub Group Coding Two researchers extracted data from each trial post treatment and where possible at follow up. Those data were checked by LW